RxDoctor Payments Data

Luciana Borio

Infectious Disease · Baltimore, MDNPI 1346206570

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $667,619 of the $671,349 with a category attached, or 99.4%. Insulet Corporation accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $299,889 and has fallen 69.5% since, to $91,446 in 2025. Among infectious disease clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$671,349in general payments, 2019–2025

Across 29 payments — averaging $23,150 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insulet Corporation$671K
  • Regeneron$198

What the payments were for

  • Speaking & faculty fees$667,61999%
  • Travel & lodging$3,5321%
  • Food & beverage$1980%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Insulet Corporation28$671,151
Regeneron1$198

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$671,349 in reported general payments places this provider in the 95th percentile of 289 infectious disease providers in Maryland.

See all infectious disease providers in Maryland →

Other infectious disease in Baltimore

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →